Capital Fund Management S.A. Nuvasive Inc Transaction History

Capital Fund Management S.A.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$35.68 - $44.71 $1.5 Million - $1.88 Million	41,958 New	41,958 $1.73 Million
Q2 2021 Aug 12, 2021	SELL	$64.02 - $71.72 $4.87 Million - $5.45 Million	-76,007 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$53.26 - $68.08 $2.53 Million - $3.24 Million	47,520 Added 166.81%	76,007 $4.98 Million
Q4 2020 Feb 12, 2021	SELL	$43.41 - $56.51 $2.35 Million - $3.07 Million	-54,249 Reduced 65.57%	28,487 $1.6 Million
Q3 2020 Nov 13, 2020	BUY	$47.43 - $60.75 $3.92 Million - $5.03 Million	82,736 New	82,736 $4.02 Million

Q2 2020 Aug 13, 2020	SELL	$43.51 - $66.59 $1.57 Million - $2.4 Million	-36,012 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$32.82 - $81.13 $1.18 Million - $2.92 Million	36,012 New	36,012 $1.82 Million
Q2 2018 Aug 14, 2018	SELL	$48.15 - $56.68 $9.46 Million - $11.1 Million	-196,476 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$46.03 - $61.28 $1.43 Million - $1.91 Million	-31,096 Reduced 13.66%	196,476 $10.3 Million
Q4 2017 Feb 09, 2018	BUY	$50.58 - $60.79 $6.84 Million - $8.22 Million	135,300 Added 146.63%	227,572 $13.3 Million
Q3 2017 Nov 13, 2017	BUY	$53.54 - $68.0 $4.94 Million - $6.27 Million	92,272	92,272 $5.12 Million

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.